EDIL3 promotes apoptosis resistance through an integrin αvβ5-KLF2-CDC20 axis in endometriosis
Current Molecular Pharmacology · 2026 · 19 (1) · 353-371
DOI: 10.1016/j.cmp.2026.09.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Deyu Zhang und 7 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Peking University First Hospital, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Peking University First Hospital
- National Natural Science Foundation of China
Zitieren
APA
Zhang, D., Zhu, J., Wu, P., Huang, Y., Wang, X., Peng, C., Zhou, Y., & Xue, Q. (2026). EDIL3 promotes apoptosis resistance through an integrin αvβ5-KLF2-CDC20 axis in endometriosis. Current Molecular Pharmacology, 19(1), 353-371. https://doi.org/10.1016/j.cmp.2026.09.004
Vancouver
Zhang D, Zhu J, Wu P, Huang Y, Wang X, Peng C, et al. EDIL3 promotes apoptosis resistance through an integrin αvβ5-KLF2-CDC20 axis in endometriosis. Current Molecular Pharmacology. 2026;19(1):353-371. doi:10.1016/j.cmp.2026.09.004
BibTeX
@article{Zhang2026,
author = {Zhang, Deyu and Zhu, Jingwen and Wu, Peili and Huang, Yan and Wang, Xiaorong and Peng, Chao and Zhou, Yingfang and Xue, Qing},
title = {EDIL3 promotes apoptosis resistance through an integrin αvβ5-KLF2-CDC20 axis in endometriosis},
journal = {Current Molecular Pharmacology},
year = {2026},
volume = {19},
number = {1},
pages = {353--371},
doi = {10.1016/j.cmp.2026.09.004}
}
EUVIMED